Loading...
•
Jun 30, 2025
Pacific Biosciences Q2 2025 Earnings Report
PacBio announced its financial results for the second quarter of 2025, reporting a return to sequential and year-over-year revenue growth, alongside reduced operating expenses and cash burn.
Key Takeaways
PacBio demonstrated a strong performance in Q2 2025, achieving revenue growth both sequentially and year-over-year, reaching $39.8 million. The company significantly reduced its GAAP net loss to $41.9 million from $173.3 million in the prior year, and improved its non-GAAP net loss to $40.0 million. This positive trend was supported by disciplined cost management and increased adoption of its HiFi sequencing platforms.
Total revenue increased to $39.8 million in Q2 2025, up from $36.0 million in Q2 2024, marking both sequential and year-over-year growth.
GAAP net loss significantly narrowed to $41.9 million in Q2 2025, a substantial improvement from a $173.3 million loss in Q2 2024.
Non-GAAP net loss also improved to $40.0 million in Q2 2025, compared to $55.2 million in the same period last year.
The company reported a GAAP gross profit of $14.7 million and a non-GAAP gross margin of 38%, indicating improved profitability.
Revenue by Segment
Forward Guidance
PacBio is focused on sustainable growth through innovation and operational efficiency, aiming to continue reducing operating expenses and cash burn while expanding the adoption of its sequencing platforms.
Positive Outlook
- Continued reduction in operating expenses.
- Ongoing efforts to reduce cash burn.
- Growing adoption of HiFi sequencing platforms.
- Momentum of Revio in clinical settings.
- Continued expansion of Vega into new markets.
Challenges Ahead
- Challenges inherent in developing, manufacturing, launching, marketing, and selling new products.
- Potential cancellation of existing instrument orders.
- Risks related to attracting new customers and retaining/growing sales from existing customers.
- Rapidly changing technologies and extensive competition in genomic sequencing.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...